The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

Antibody–drug conjugates (ADCs) represent one of the most transformative advances in precision oncology over the past two decades and are increasingly positioned to replace conventional chemotherapy ...

Artificial intelligence may help doctors identify serious symptoms in childhood cancer survivors—especially when models are guided with richer prompts.

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections - but with fewer of the worst side-effects ...